SCHEMBL3591632

SCHEMBL3591632

CC(C)(C)c1ccc(C(C(=O)O)c2ccc(C(C)(C)C)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 3/20 0.50
SRD5A2 P31213 1/20 0.48
AKR1C3 P42330 1/20 0.47
AKR1C2 P52895 1/20 0.47
HDAC1 Q13547 1/20 0.45
FFAR1 O14842 1/20 0.45
LMNA P02545 1/20 0.44
TYR P14679 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
RARB P10826 1/20 0.44
RARG P13631 1/20 0.44
TSHR P16473 2/20 0.44
ALDH1A1 P00352 1/20 0.44
HSD17B10 Q99714 1/20 0.44
KIF11 P52732 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
HIF1A Q16665 1/20 0.42
CYP1A2 P05177 1/20 0.42
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL31045512 0.98 NR1H4 (0.53) NR1H4SRD5A2AKR1C3AKR1C2HDAC1
SCHEMBL6951155 0.83 SRC (0.54) NR1H4SRD5A2AKR1C3AKR1C2HDAC1
SCHEMBL28314596 0.81 SRC (0.52) NR1H4SRD5A2AKR1C3AKR1C2HDAC1
SCHEMBL1716479 0.81 NR1H4 (0.71) NR1H4SRD5A2AKR1C3AKR1C2HDAC1
SCHEMBL28314762 0.81 SRC (0.52) NR1H4SRD5A2AKR1C3AKR1C2HDAC1
SCHEMBL11238948 0.81 LMNA (0.56) NR1H4SRD5A2AKR1C3AKR1C2HDAC1
SCHEMBL21269797 0.81 SRC (0.52) NR1H4SRD5A2AKR1C3AKR1C2HDAC1
SCHEMBL21269219 0.81 SRC (0.52) NR1H4SRD5A2AKR1C3AKR1C2HDAC1
SCHEMBL21268997 0.81 SRC (0.52) NR1H4SRD5A2AKR1C3AKR1C2HDAC1
SCHEMBL28314648 0.81 SRC (0.52) NR1H4SRD5A2AKR1C3AKR1C2HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118271508-A Polymer, photoresist composition comprising the same, and pattern forming method 罗门哈斯电子材料有限责任公司 2024-07-02 CN disclosed
CN-116891409-A Photoactive compound, photoresist composition comprising the same, and pattern forming method 罗门哈斯电子材料有限责任公司 2023-10-17 CN disclosed
US-7714167-B2 Catalytic asymmetric epoxidation UNIVERSITY OF CHICAGO (US) 2010-05-11 US disclosed
US-7714167-B2 Catalytic asymmetric epoxidation UNIVERSITY OF CHICAGO (US) 2010-05-11 US disclosed
US-7714167-B2 Catalytic asymmetric epoxidation UNIVERSITY OF CHICAGO (US) 2010-05-11 US disclosed
EP-1706205-B1 A CATALYTICAL ASYMMETRIC EPOXIDATION UNIV CHICAGO (US) 2008-10-29 EP disclosed
US-20070203347-A1 Catalytic asymmetric epoxidation THE UNIVERSITY OF CHICAGO (US) 2007-08-30 US disclosed
US-20070203347-A1 Catalytic asymmetric epoxidation THE UNIVERSITY OF CHICAGO (US) 2007-08-30 US disclosed
US-20070203347-A1 Catalytic asymmetric epoxidation THE UNIVERSITY OF CHICAGO (US) 2007-08-30 US disclosed
US-7202371-B2 Catalytic asymmetric epoxidation THE UNIVERSITY OF CHICAGO (US) 2007-04-10 US disclosed
US-7202371-B2 Catalytic asymmetric epoxidation THE UNIVERSITY OF CHICAGO (US) 2007-04-10 US disclosed
US-7202371-B2 Catalytic asymmetric epoxidation THE UNIVERSITY OF CHICAGO (US) 2007-04-10 US disclosed
US-20050159607-A1 Catalytic asymmetric epoxidation JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2005-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203347-A1 Catalytic asymmetric epoxidation DUOX1, DUOX2, EPHX2 NR1H4 567/4885SRD5A2 31/4885AKR1C3 274/4885
US-20050159607-A1 Catalytic asymmetric epoxidation DUOX1, DUOX2, EPHX2 NR1H4 567/4885SRD5A2 31/4885AKR1C3 274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.